BACKGROUND Germline mutations in telomerase and other telomere maintenance genes manifest in the premature aging short telomere syndromes. Myelodysplastic syndromes and acute myeloid leukemia (MDS/AML) account for 75% of associated malignancies, but how these cancers overcome the inherited telomere defect is unknown.METHODS We used ultra-deep targeted sequencing to detect somatic reversion mutations in 17 candidate telomere lengthening genes among controls and patients with short telomere syndromes with and without MDS/AML, and we tested the functional significance of these mutations.RESULTS While no controls carried somatic mutations in telomere maintenance genes, 29% (16 of 56) of adults with germline telomere maintenance defects carried at least 1 (P < 0.001), and 13% (7 of 56) had 2 or more. In addition to TERT promoter mutations, which were present in 19%, another 13% of patients carried a mutation in POT1 or TERF2IP. POT1 mutations impaired telomere binding in vitro and some mutations were identical to ones seen in familial melanoma associated with longer telomere length. Exclusively in patients with germline defects in telomerase RNA (TR), we identified somatic mutations in nuclear RNA exosome genes RBM7, SKIV2L2, and DIS3, where loss-of-function upregulates mature TR levels. Somatic reversion events in 6 telomere-related genes were more prevalent in patients who were MDS/AML-free (P = 0.02, RR 4.4, 95% CI 1.2–16.7), and no patient with MDS/AML had more than 1 reversion mutation.CONCLUSION Our data indicate that diverse adaptive somatic mutations arise in the short telomere syndromes. Their presence may alleviate the telomere crisis that promotes transformation to MDS/AML.FUNDING This work was supported by the NIH, the Commonwealth Foundation, the S&R Foundation Kuno Award, the Williams Foundation, the Vera and Joseph Dresner Foundation, the MacMillan Pathway to Independence Award, the American Society of Hematology Scholar Award, the Johns Hopkins Research Program for Medical Students, and the Turock Scholars Fund.
Kristen E. Schratz, Valeriya Gaysinskaya, Zoe L. Cosner, Emily A. DeBoy, Zhimin Xiang, Laura Kasch-Semenza, Liliana Florea, Pali D. Shah, Mary Armanios
Title and authors | Publication | Year |
---|---|---|
ATM-dependent DNA damage response constrains cell growth and drives clonal hematopoiesis in telomere biology disorders
Christopher M. Sande, Stone Chen, Dana V. Mitchell, Ping Lin, Diana M. Abraham, Minxuan Cheng, Talia Gebhard, Rujul J. Deolikar, Colby Freeman, Mary Zhou, Sushant Kumar, Michael Bowman, Robert L. Bowman, Shannon Zheng, Bolormaa Munkhbileg, Qijun Chen, Natasha L. Stanley, Kathy Guo, Ajibike Lapite, Ryan Hausler, Deanne M. Taylor, James Corines, Jennifer J.D. Morrissette, David Lieberman, Guang Yang, Olga Shestova, Saar Gill, Jiayin Zheng, Kelcy Smith-Simmer, Lauren G. Banaszak, Kyle N. Shoger, Erica F. Reinig, Madilynn Peterson, Peter Nicholas, Amanda J. Walne, Inderjeet Dokal, Justin P. Rosenheck, Karolyn A. Oetjen, Daniel C. Link, Andrew E. Gelman, Christopher R. Reilly, Ritika Dutta, R. Coleman Lindsley, Karyn J. Brundige, Suneet Agarwal, Alison A. Bertuch, Jane E. Churpek, Laneshia K Tague, F. Brad Johnson, Timothy S Olson, Daria V. Babushok |
Journal of Clinical Investigation | 2025 |
Viewpoint: Pre- and post-lung transplant considerations for patients with ultra-short telomere length
Shah PD, Armanios M |
The European Respiratory Journal | 2025 |
Azacitidine and venetoclax for the treatment of AML arising from an underlying telomere biology disorder.
Pandey A, Mancuso T, Velsher L, Kennedy JA |
Familial cancer | 2025 |
Increased Frequency of Clonal Hematopoiesis of Indeterminate Potential in Bloom Syndrome Probands and Carriers.
Lin I, Wei A, Gebo TA, Boutros PC, Flanagan M, Kucine N, Cunniff C, Arboleda VA, Chang VY |
medRxiv : the preprint server for health sciences | 2024 |
Genetically determined telomere length as a risk factor for hematological malignancies: evidence from Mendelian randomization analysis
Fang T, Zhang Z, Ren K, Zou L |
Aging | 2024 |
Genetic variation across and within individuals.
Yu Z, Coorens THH, Uddin MM, Ardlie KG, Lennon N, Natarajan P |
Nature reviews. Genetics | 2024 |
Telomere-lengthening germline variants predispose to a syndromic papillary thyroid cancer subtype
DeBoy EA, Nicosia AM, Liyanarachchi S, Iyer SS, Shah MH, Ringel MD, Brock P, Armanios M |
The American Journal of Human Genetics | 2024 |
Mendelian randomization analysis reveals the combined effects of epigenetics and telomere biology in hematologic cancers
Zhuang X, Chen P, Yang R, Man X, Wang R, Shi Y |
Clinical Epigenetics | 2024 |
The evolving genetic landscape of telomere biology disorder dyskeratosis congenita.
Tummala H, Walne AJ, Badat M, Patel M, Walne AM, Alnajar J, Chow CC, Albursan I, Frost JM, Ballard D, Killick S, Szitányi P, Kelly AM, Raghavan M, Powell C, Raymakers R, Todd T, Mantadakis E, Polychronopoulou S, Pontikos N, Liao T, Madapura P, Hossain U, Vulliamy T, Dokal I |
EMBO molecular medicine | 2024 |
Update on Recommendations for Surveillance for Children with Predisposition to Hematopoietic Malignancy
Maese LD, Wlodarski MW, Kim SY, Bertuch AA, Bougeard G, Chang VY, Godley LA, Khincha PP, Kuiper RP, Lesmana H, McGee RB, McReynolds LJ, Meade J, Plon SE, Savage SA, Scollon SR, Scott HS, Walsh MF, Nichols KE, Porter CC |
Clinical cancer research : an official journal of the American Association for Cancer Research | 2024 |
Different phenotypes with different endings—Telomere biology disorders and cancer predisposition with long telomeres
Savage SA, Bertuch AA |
British Journal of Haematology | 2024 |
Clonal landscape and clinical outcomes of telomere biology disorders: somatic rescue and cancer mutations
Gutierrez-Rodrigues F, Groarke EM, Thongon N, Rodriguez-Sevilla JJ, Catto LF, Niewisch MR, Shalhoub R, McReynolds LJ, Clé DV, Patel BA, Ma X, Hironaka D, Donaires FS, Spitofsky N, Santana BA, Lai TP, Alemu L, Kajigaya S, Darden I, Zhou W, Browne PV, Paul S, Lack J, Young DJ, DiNardo CD, Aviv A, Ma F, De Oliveira MM, de Azambuja AP, Dunbar CE, Olszewska M, Olivier E, Papapetrou EP, Giri N, Alter BP, Bonfim C, Wu CO, Garcia-Manero G, Savage SA, Young NS, Colla S, Calado RT |
Blood | 2024 |
A perspective of immunotherapy for acute myeloid leukemia: Current advances and challenges
Chen Y, Wang J, Zhang F, Liu P |
Frontiers in pharmacology | 2023 |
T cell immune deficiency rather than chromosome instability predisposes patients with short telomere syndromes to squamous cancers
Schratz KE, Flasch DA, Atik CC, Cosner ZL, Blackford AL, Yang W, Gable DL, Vellanki PJ, Xiang Z, Gaysinskaya V, Vonderheide RH, Rooper LM, Zhang J, Armanios M |
Cancer Cell | 2023 |
Telomere biology: from disorders to hematological diseases
Roka K, Solomou EE, Kattamis A |
Frontiers in Oncology | 2023 |
Familial Clonal Hematopoiesis in a Long Telomere Syndrome
DeBoy EA, Tassia MG, Schratz KE, Yan SM, Cosner ZL, McNally EJ, Gable DL, Xiang Z, Lombard DB, Antonarakis ES, Gocke CD, McCoy RC, Armanios M |
The New England journal of medicine | 2023 |
Clonal evolution in inherited marrow failure syndromes predicts disease progression
Schratz KE |
2023 | |
Lung transplant recipients with telomere-mediated pulmonary fibrosis have increased risk for hematologic complications.
Hannan SJ, Iasella CJ, Sutton RM, Popescu ID, Koshy R, Burke R, Chen X, Zhang Y, Pilewski JM, Hage CA, Sanchez PG, Im A, Farah R, Alder JK, McDyer JF |
American Journal of Transplantation | 2023 |
Cell senescence and malignant transformation in the inherited bone marrow failure syndromes: Overlapping pathophysiology with therapeutic implications
E Groarke, R Calado, J Liu |
Seminars in Hematology | 2022 |
Clonal Hematopoiesis and Myeloid Neoplasms in the Context of Telomere Biology Disorders
A Ferrer, A Mangaonkar, M Patnaik |
Current Hematologic Malignancy Reports | 2022 |
Telomere-mediated lung disease
Alder JK, Armanios M |
Physiological reviews | 2022 |
Recent advances in understanding telomere diseases.
Carvalho VS, Gomes WR, Calado RT |
2022 | |
Alveolar type 2 epithelial cell senescence and radiation-induced pulmonary fibrosis
Zhou S, Zhu J, Zhou PK, Gu Y |
Frontiers in Cell and Developmental Biology | 2022 |
Editing TINF2 as a potential therapeutic approach to restore telomere length in dyskeratosis congenita.
Choo S, Lorbeer FK, Regalado SG, Short SB, Wu S, Rieser G, Bertuch AA, Hockemeyer D |
Blood | 2022 |
Genetics in Idiopathic Pulmonary Fibrosis: A Clinical Perspective
Papiris SA, Kannengiesser C, Borie R, Kolilekas L, Kallieri M, Apollonatou V, Ba I, Nathan N, Bush A, Griese M, Dieude P, Crestani B, Manali ED |
Diagnostics | 2022 |
Dyskeratosis congenita and telomere biology disorders
Savage SA |
2022 | |
The Role of Telomeres in Human Disease.
Armanios M |
Annual Review of Genomics and Human Genetics | 2022 |
Clonal hematopoiesis and inflammation – the perpetual cycle
Avagyan S, Zon LI |
Trends in Cell Biology | 2022 |